News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Incyte Corporation (INCY) Reports 2014 First-Quarter Financial Results And Updates Shareholders On Key Clinical Programs


5/1/2014 2:54:02 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Incyte Corporation (Nasdaq: INCY) today reported 2014 first-quarter financial results, including revenue from JakafiĀ® (ruxolitinib), which is approved by the U.S. Food & Drug Administration (FDA) for the treatment of patients with intermediate or high-risk myelofibrosis (MF).

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES